Listed Japanese companies ranked by revenue in their latest fiscal year.
64 listed companies (total ¥17.86T)
| # | Company | Revenue | Net income | Taxes paid | Total assets |
|---|---|---|---|---|---|
| 1 | Takeda Pharmaceutical Company Limited | ¥4.51T | −¥152B | ¥180B | ¥15.51T |
| 2 | Otsuka Holdings Co., Ltd. | ¥2.47T | ¥363B | ¥74.0B | ¥4.20T |
| 3 | Astellas Pharma Inc. | ¥2.14T | ¥292B | ¥98.6B | ¥3.57T |
| 4 | Daiichi Sankyo Company, Limited | ¥2.12T | ¥280B | ¥128B | ¥4.00T |
| 5 | Chugai Pharmaceutical Co., Ltd. | ¥1.26T | ¥434B | ¥191B | ¥2.47T |
| 6 | Eisai Co., Ltd. | ¥825B | ¥38.6B | ¥16.7B | ¥1.45T |
| 7 | ONO Pharmaceutical Co., Ltd. | ¥516B | ¥69.8B | ¥16.4B | ¥1.11T |
| 8 | Shionogi & Co.,Ltd. | ¥500B | ¥205B | ¥41.0B | ¥2.58T |
| 9 | Kyowa Kirin Co.,Ltd. | ¥497B | ¥67.0B | ¥0 | ¥1.11T |
| 10 | Sumitomo Pharma Co., Ltd. | ¥453B | ¥107B | ¥4.6B | ¥805B |
| 11 | Rohto Pharmaceutical Co., Ltd. | ¥344B | ¥34.2B | ¥11.9B | ¥486B |
| 12 | Santen Pharmaceutical Co., Ltd. | ¥292B | ¥37.4B | ¥7.4B | ¥423B |
| 13 | TOWA Pharmaceutical Co., Ltd. | ¥274B | ¥5.2B | ¥8.5B | ¥475B |
| 14 | SAWAI GROUP HOLDINGS Co., Ltd. | ¥202B | ¥10.4B | ¥1.8B | ¥360B |
| 15 | Tsumura & Co. | ¥193B | ¥28.1B | ¥12.6B | ¥593B |
| 16 | Nippon Shinyaku Co.,Ltd. | ¥171B | ¥29.7B | ¥10.2B | ¥346B |
| 17 | KYORIN Pharmaceutical Co., Ltd. | ¥126B | ¥3.4B | ¥2.9B | ¥195B |
| 18 | Mochida Pharmaceutical Co.,Ltd. | ¥117B | ¥7.9B | ¥2.4B | ¥183B |
| 19 | Kissei Pharmaceutical Co., Ltd. | ¥97.4B | ¥13.8B | ¥3.4B | ¥275B |
| 20 | Zeria Pharmceutical Co., Ltd. | ¥89.2B | ¥8.5B | ¥2.7B | ¥180B |
| 21 | Kaken Pharmaceutial Co., Ltd. | ¥76.9B | ¥2.1B | ¥10.7B | ¥178B |
| 22 | ASKA Pharmaceutical Holdings CO., Ltd. | ¥71.1B | ¥5.4B | ¥241M | ¥112B |
| 23 | Fuso Pharmaceutical Industries,Ltd. | ¥62.3B | ¥2.0B | ¥1.3B | ¥90.3B |
| 24 | Fuji Pharma Co.,Ltd. | ¥51.7B | ¥3.0B | ¥2.2B | ¥93.4B |
| 25 | Daito Pharmaceutical Co., Ltd. | ¥50.6B | ¥3.2B | ¥729M | ¥73.3B |
| 26 | Eiken Chemical Co., Ltd. | ¥41.9B | ¥3.7B | ¥754M | ¥62.7B |
| 27 | JCR Pharmaceuticals Co.,Ltd. | ¥40.3B | ¥2.2B | ¥0 | ¥109B |
| 28 | Seikagaku Corporation | ¥36.6B | ¥1.5B | ¥17.0M | ¥86.3B |
| 29 | Nippon Chemiphar Co., Ltd. | ¥33.1B | ¥198M | ¥105M | ¥50.0B |
| 30 | Nxera Pharma Co., Ltd. | ¥29.6B | −¥12.5B | ¥241M | ¥135B |
| 31 | GNI Group Ltd. | ¥26.8B | −¥4.2B | ¥763M | ¥83.8B |
| 32 | KOA Shoji Holdings Co., Ltd. | ¥24.7B | ¥3.7B | ¥1.9B | ¥39.5B |
| 33 | PeptiDream Inc. | ¥18.5B | −¥3.7B | ¥8.1B | ¥77.0B |
| 34 | YUKI Gosei Kogyo Co., Ltd. | ¥15.4B | ¥313M | ¥226M | ¥25.7B |
| 35 | TAUNS Laboratories, Inc. | ¥14.4B | ¥5.5B | ¥1.8B | ¥44.6B |
| 36 | Morishita Jintan Co., Ltd. | ¥12.7B | ¥628M | ¥33.0M | ¥18.6B |
| 37 | Mizuho MEDY Co., Ltd. | ¥11.3B | ¥3.4B | ¥1.2B | ¥22.4B |
| 38 | Wakamoto Pharmaceutical Co., Ltd. | ¥9.9B | ¥227M | ¥25.4M | ¥16.5B |
| 39 | Muromachi Chemicals Inc. | ¥7.8B | ¥163M | ¥159M | ¥6.4B |
| 40 | Kidswell Bio Corporation | ¥6.6B | −¥414M | ¥152M | ¥6.1B |
| 41 | Chukyoiyakuhin Co., Ltd. | ¥6.6B | ¥83.6M | ¥62.4M | ¥5.3B |
| 42 | Taiko Pharmaceutical Co., Ltd. | ¥6.4B | ¥923M | ¥34.0M | ¥12.3B |
| 43 | Kohjin Bio Co., Ltd. | ¥4.9B | ¥251M | ¥228M | ¥8.9B |
| 44 | Ｈｅａｒｔｓｅｅｄ株式会社 | ¥3.0B | ¥191M | ¥107M | ¥7.7B |
| 45 | StemCell Institute Inc. | ¥2.8B | ¥156M | ¥184M | ¥8.1B |
| 46 | SymBio Pharmaceuticals Limited | ¥1.3B | −¥4.8B | ¥12.6M | ¥3.9B |
| 47 | Immuno-Biological Laboratories Co., Ltd. | ¥1.0B | ¥329M | ¥5.5M | ¥2.2B |
| 48 | 株式会社ＰＲＩＳＭ ＢｉｏＬａｂ | ¥677M | −¥834M | ¥1.3M | ¥3.1B |
| 49 | Chiome Bioscience Inc. | ¥593M | −¥983M | ¥3.6M | ¥1.7B |
| 50 | Carna Biosciences, Inc. | ¥579M | −¥2.2B | ¥0 | ¥1.2B |
| 51 | ソレイジア・ファーマ株式会社 | ¥429M | −¥876M | ¥0 | ¥2.1B |
| 52 | D.Western Therapeutics Institute, Inc. | ¥388M | −¥632M | ¥1.9M | ¥2.2B |
| 53 | ステラファーマ株式会社 | ¥323M | −¥781M | ¥2.9M | ¥4.5B |
| 54 | 株式会社サイフューズ | ¥231M | −¥764M | ¥2.5M | ¥4.3B |
| 55 | Cuorips Inc. | ¥212M | −¥1.0B | ¥2.9M | ¥5.1B |
| 56 | Nano Holdings, Inc. | ¥174M | −¥944M | ¥2.9M | ¥5.9B |
| 57 | Perseus Proteomics Inc. | ¥136M | −¥718M | ¥3.2M | ¥1.6B |
| 58 | 株式会社メドレックス | ¥128M | −¥937M | ¥3.2M | ¥2.2B |
| 59 | Healios K.K. | ¥104M | −¥2.2B | ¥4.0M | ¥17.1B |
| 60 | Kringle Pharma,Inc. | ¥72.2M | −¥916M | ¥1.5M | ¥2.1B |
| 61 | Oncolys BioPharma Inc. | ¥28.5M | −¥2.1B | ¥4.0M | ¥4.6B |
| 62 | Kubota Pharmaceutical Holdings Co., Ltd. | ¥21.3M | −¥676M | — | ¥2.0B |
| 63 | RIBOMIC Inc. | ¥3.0M | −¥1.1B | ¥2.4M | ¥3.0B |
| 64 | BrightPath Biotherapeutics Co., Ltd. | ¥84,000 | −¥1.3B | ¥1.9M | ¥2.6B |
From the latest annual securities reports filed with EDINET. Fiscal years differ by company.